'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end. (Q38995855)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2014

Language	Label	Description	Also known as
English	'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.	scientific article published on August 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Toin H van Kuppevelt

5

object named as

Toin H van Kuppevelt

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Xander M R van Wijk

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Arie Oosterhof

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Elly M M Versteeg

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Els M A van de Westerlo

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

1 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Biochemical Journal

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

461

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

461-468

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Heparan sulphate proteoglycans fine-tune mammalian physiology

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Order out of chaos: assembly of ligand binding sites in heparan sulfate

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Heterogeneity of heparan sulfates in human lung

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Specificity studies on the heparin lyases from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Action pattern of polysaccharide lyases on glycosaminoglycans.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Characterizing the non-reducing end structure of heparan sulfate

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Characterization of anticoagulant heparinoids by immunoprofiling

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Identifiers

10.1042/BJ20140355

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38995855&oldid=1511265239"